TCL Archive NCI advisors approve recompetition of $62 million phase II contracts program. November 19, 2004
TCL Archive Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL July 11, 2014
TCL Archive Pursuit Of Truth Was Not An NIH Objective In Gallo Case, Dingell Staff Report Says January 6, 1995
TCL Archive Spending Measures Include Provisions On Ethics For NIH Extramural Scientists. July 11, 2008
